From the The First Clinical Medical College, Lanzhou University.
Pancreas. 2021 Jan 1;50(1):12-16. doi: 10.1097/MPA.0000000000001713.
Despite great progress in the treatment of pancreatic cancer under the efforts of researchers, the survival time of patients with pancreatic cancer is shorter than that of patients with other cancers. Thus, we have a great need for innovative therapeutic methods, including research and development of new drugs and innovation of administration methods. Exosomes are a type of extracellular vesicles wrapped by a lipid bilayer. Thanks to the low clearance ratio and strong specificity of exosomes in circulation, together with in-depth research on the surface protein of exosomes and a targeted modification method, there is a strong potential to apply exosomes in the transfer and even targeted delivery of chemotherapeutics, RNA, and natural products. Particularly, exosomes carrying microRNA show good application prospects in cancer therapy. This article is intended to summarize the progress of research relating to the treatment of pancreatic cancer via exosomal microRNAs.
尽管研究人员在胰腺癌治疗方面取得了巨大进展,但胰腺癌患者的生存时间仍短于其他癌症患者。因此,我们非常需要创新的治疗方法,包括新药物的研发和给药方式的创新。外泌体是一种由脂质双层包裹的细胞外囊泡。由于外泌体在循环中的清除率低且特异性强,再加上对外泌体表面蛋白的深入研究和靶向修饰方法,外泌体在化疗药物、RNA 和天然产物的传递甚至靶向递送方面具有很大的应用潜力。特别是,携带 microRNA 的外泌体在癌症治疗中具有良好的应用前景。本文旨在总结通过外泌体 microRNA 治疗胰腺癌的研究进展。